Please login to the form below

Not currently logged in
Email:
Password:

business models

This page shows the latest business models news and features for those working in and with pharma, biotech and healthcare.

The Midas Touch

The Midas Touch

So too is the push towards business models that create value beyond the pill, as we are beginning to see in chronic diseases like asthma and diabetes. ... to myopically focus on the big bet, big risk, big pay-off business models.

Latest news

  • Safety first: AI adoption in the healthcare sector Safety first: AI adoption in the healthcare sector

    Vendor and product selection: allow sufficient time for procurement and contracting, develop and validate business requirements, and carefully assess the market. - ... use of massively complex (and perhaps not fully understood) algorithms. Businesses and

  • Big Pharma, Little Pharma Big Pharma, Little Pharma

    Professor Brian D Smith is an authority on the pharmaceutical industry and works at SDA Bocconi University and Hertfordshire Business School. ... We should expect a much more distributed industry with market share spread over a large number of species of

  • Collaborate to survive Collaborate to survive

    We should expect a flowering of business models as dramatic as that seen by our great-great-grandparents, marked by the survival of those who anticipated the change and the extinction

  • Segmentation, evolved Segmentation, evolved

    Well done you! So how is this relevant to the evolution of business models in the life science industry? ... a cluster of adaptations - from early market access involvement to re-engineered metrics - that I’ve observed in the evolution of various

  • Life science companies can’t keep up with technology competitors Life science companies can’t keep up with technology competitors

    The report warns that the sector needs to look beyond novel drugs and devices by creating new business models to provide data-driven health services, ones that are more ‘convenient’and ... Success in this new market paradigm requires the adoption of

More from news
Approximately 13 fully matching, plus 118 partially matching documents found.

Latest Intelligence

  • Lonely planet: why there is dwindling value in pharma travelling alone Lonely planet: why there is dwindling value in pharma travelling alone

    To develop sustainable business models that establish value ‘beyond the pill’, collaboration is the best way forward. " /. ... If companies are to develop sustainable business models that establish value ‘beyond the pill’, collaboration is the

  • KAM 2.0 KAM 2.0

    Very few have transformed their business models towards long- term key account partnerships that truly engage cross-functional teams working closely together to deliver on specific account needs. ... figure) – programme focus (internal and/ or key

  • The rise of vertical integration in the US payer landscape The rise of vertical integration in the US payer landscape

    As CVS and Cigna face the looming entry of Amazon, Berkshire and JP Morgan into the healthcare space, their business models will come under continued pressure. ... As mentioned, organisational outlook is often different based on orientation and business

  • Can new data aggregators shift the balance of power away from pharma? Can new data aggregators shift the balance of power away from pharma?

    or new stakeholders with novel technology or business models. ... The fact that innovation outside the core drug discovery business is considered to be anathema by pharma companies has been explained by the need to adhere to strict rules and regulations.

  • 30 Women Leaders in UK Healthcare

    Joanne Hackett and the Genomics England team are still developing business models for external access to the data, but if they can find the right formula for this (while safeguarding data ... It’s time to talk to business − and forge partnerships on

More from intelligence
Approximately 6 fully matching, plus 22 partially matching documents found.

Latest appointments

  • Huntingdon Life Sciences appoints Joseph Bedford Huntingdon Life Sciences appoints Joseph Bedford

    The job spans the company's contract research services (CRS) and research models services (RMS) business units, with responsibility for global marketing, business intelligence, strategic planning and some aspects of corporate

  • Lilly names head of corporate business development Lilly names head of corporate business development

    During his career at the company, Carroll has helped lead and create new business models for the firm including e-Lilly, InnoCentive, Lilly Ventures and Lilly Asia Ventures. ... He is a pragmatic, creative individual with an extraordinary bandwidth for

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Digital trends in B2B sales - how far behind is Pharma?

    The impact of digital has fundamentally changed business models across UK industries over the last 10, or so, years. ... Even when they’ re shopping for their business, they expect an experience like B2C.”.

  • What's holding you back?

    functions. Don’ t get left behind in the race to find a successful new business model! ... In this article we talk about the opportunities that these challenges bring, learning from others to accelerate change, what new world business models could look

  • A MacCulloch Associates 'AMA' Ltd

    Working as an extension of your organisation, we devise perfect event business models that grow professional, approachable, caring brands and create wealth. ... Address:. 3 Arrow Court. Adams Way , Springfield Business Park. Alcester.

More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics